EP Patent

EP0968183A2 — 13-thia prostaglandins for use in glaucoma therapy

Assigned to Alcon Vision LLC · Expires 2000-01-05 · 26y expired

What this patent protects

13-thia prostaglandins are useful in the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic, pharmaceutical compositions comprising said prostaglandins.

USPTO Abstract

13-thia prostaglandins are useful in the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic, pharmaceutical compositions comprising said prostaglandins.

Drugs covered by this patent

Patent Metadata

Patent number
EP0968183A2
Jurisdiction
EP
Classification
—
Expires
2000-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Alcon Vision LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.